Abstract
Two characteristic features of malignant gliomas (MG) are the presence of hypoxia and accumulation of regulatory T cells (Tregs). Heme-oxygenase-1 (HO1) is a cytoprotective enzyme expressed in high level by Tregs in glioma. In this study, we show that higher HO1 expression in Tregs is associated with increased survival under hypoxic conditions and that HO1 inhibitor, tin protoporphyrin (SnPP), abrogates the survival benefits. Moreover, SnPP preferentially eliminates Tregs and treatment with SnPP of tumor bearing mice significantly increases survival (23 to 31. days (p<. 0.05)). Thus HO1 inhibition provides another alternative way of therapeutically targeting Tregs in MG.
Original language | English (US) |
---|---|
Pages (from-to) | 33-42 |
Number of pages | 10 |
Journal | Journal of Neuroimmunology |
Volume | 266 |
Issue number | 1-2 |
DOIs | |
State | Published - Jan 15 2014 |
Keywords
- Glioma
- Heme oxygenase 1
- Hypoxia
- Immunization
- Regulatory T cells
- Tin protoporphyrin
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Neurology
- Clinical Neurology